Press-release for stocks

| -80.08% | O: -3.29% H: 3.0% C: -6.0%
positive results positive results trial

AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ® (Upadacitinib) Among Patients with Rheumatoid Arthritis
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

| 40.97% | O: -0.84% H: 0.0% C: 0.0%
rheumatoid arthritis response

MKS Instruments to Participate in Deutsche Bank’s Industrial Conference
Published: 2021-11-08 (Crawled : 14:15) - globenewswire.com
MKSI | $108.1 -3.56% -3.69% 770K

Electronic Technology

| -28.37% | O: 0.22% H: 0.54% C: -1.11%
trial conference

American Airlines to Present at 2021 Baird Global Industrial Conference
Published: 2021-11-03 (Crawled : 14:15) - globenewswire.com
GIC | $40.52 0.87% 0.0% 56K

Retail Trade

| -4.36% | O: -2.26% H: 0.0% C: 0.0%
AAL | $14.1 0.57% 0.57% 27M

Transportation

| -34.29% | O: -0.05% H: 4.29% C: 4.09%
trial conference

BioVie Announces FDA Authorization to Initiate Phase 2 Trials Assessing NE3107’s Pro-motoric Activity in Parkinson’s Disease
Published: 2021-10-26 (Crawled : 14:15) - biospace.com/
BIVI | $0.4874 -0.21% -0.21% 490K

| -91.03% | O: 6.04% H: 0.0% C: 0.0%
disease fda phase 2 parkinson trials trial

With Market Size Valued at $1.3 Billion by 2026, it`s a Healthy Outlook for the Global Industrial Communication Gateways Market
Published: 2021-10-19 (Crawled : 14:15) - prnewswire.com
GIC | $40.52 0.87% 0.0% 56K

Retail Trade

| 1.45% | O: 0.65% H: 2.29% C: 1.97%
EMR | $108.58 -0.67% 0.0% 2.1M

| 16.41% | O: 0.7% H: 0.15% C: -0.02%
CSCO | $48.33 0.46% 0.46% 20M

Technology Services

| -12.59% | O: 0.18% H: 0.89% C: 0.81%
communication trial

USD 642.89 mn growth in Industrial Food Dryer Market | Increase in demand for Freeze Drying Equipment to Accelerate Market Demand | 17,000+ Technavio Research Reports
Published: 2021-10-15 (Crawled : 14:15) - prnewswire.com
ADRZY | $12.1275 -17.72% 2.8K

| Email alert Add to watchlist
ADRZF | $58.8 -0.83% 1.5K

| Email alert Add to watchlist
food ema growth research trial

Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple solid tumors
Published: 2021-10-13 (Crawled : 14:15) - globenewswire.com
SRNE | $0.024 -8.85% 57K

| -99.69% | O: 2.45% H: 0.52% C: -0.15%
fda clearance fda solid tumors antibody drug trial clearance

Cameco and Terrestrial Energy to Examine Partnerships for Deploying IMSR Generation IV Nuclear Power Plants
Published: 2021-10-13 (Crawled : 14:15) - globenewswire.com
CCJ | $48.1 -0.15% 0.02% 2.2M

Non-Energy Minerals

| 96.77% | O: -0.78% H: 6.5% C: 5.51%
partnership energy trial

Industrial Robots Market in Automotive Industry to grow by USD 3.97 Bn | APAC to Occupy 67% Market Share | Technavio
Published: 2021-10-12 (Crawled : 14:15) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K

| 32.34% | O: -1.97% H: 0.78% C: -1.62%
SEKEY | $8.47 -1.89% 14K

| -12.88% | O: 0.05% H: 0.0% C: -0.51%
DNZOY | $18.47 0.08% 47K

| -43.64% | O: -0.24% H: 0.6% C: 0.15%
ABB | News | $37.13 -0.03% 6.4M

| 13.9% | O: 1.87% H: 0.03% C: -0.54%
automotive trial

Axalta expands Imron® Industrial portfolio with a new high-performance urethane DTM primer
Published: 2021-10-07 (Crawled : 14:15) - prnewswire.com
AXTA | $30.87 -2.96% 0.0% 4.9M

Process Industries

| 8.12% | O: 0.99% H: 2.95% C: 2.21%
trial primec

Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
Published: 2021-10-05 (Crawled : 14:15) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M

| -92.55% | O: 0.06% H: 1.55% C: -5.41%
vaccine trial

Oncorus to Present Initial Data from its Ongoing Phase 1 Clinical Trial of ONCR-177 at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ONCR | $0.126 -75.95% 140K

| -98.61% | O: -0.11% H: 1.61% C: 0.21%
immunotherapy ongoing phase 1 therapy cancer trial

Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)
Published: 2021-09-28 (Crawled : 14:15) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

| -95.96% | O: -0.59% H: 0.3% C: -2.44%
stroke phase 2 neurological life science

Care Access and Eli Lilly and Company Partner to Increase Diversity Within Oncology Clinical Trials
Published: 2021-09-28 (Crawled : 14:15) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 231.61% | O: -0.0% H: 0.0% C: -2.12%
clinical trials trials trial

Mirati Therapeutics Announces Long-term Survival Results from an Exploratory Analysis of Sitravatinib plus Nivolumab in Patients with Non-squamous Non-Small Cell Lung Cancer Who are Resistant to Checkpoint Inhibitors
Published: 2021-09-20 (Crawled : 14:15) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0

| -65.56% | O: 0.78% H: 11.36% C: 3.1%
lung cancer results cancer nivolumab

Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
Published: 2021-09-14 (Crawled : 14:15) - biospace.com/
APRE | $5.65 0.71% 0.71% 7.2K

| 32.95% | O: 1.82% H: 6.7% C: 0.89%
solid tumors phase 1 trial phase 2 phase 3

J&J on Pace for Another Vaccine Success, this Time for Ebola
Published: 2021-09-14 (Crawled : 14:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M